References
S. B. Charnick, R. Kawai, J. R. Nedelman, M. Lemaire, W. Niederberger, and H. Sato. Physiologically based pharmacokinetic modeling as a tool for drug development.J. Pharmacokin. Biopharm.23:213–225.
D. Verotta, L. B. Sheiner, W. F. Ebling, and D. R. Stanski. A semiparametric approach to physiological flow models.J. Pharmacokin. Biopharm. 17:463–491 (1989).
D. Verotta, L. B. Sheiner, and S. L. Beal. Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).J. Pharmacokin. Biopharm. 19:319–331 (1991).
W. F. Ebling, D. R. Wada, and D. R. Stanski. From piecewise to full physiologic modeling: Applied to thiopental disposition in the rat.J. Pharmacokin. Biopharm. 22:259–292 (1994).
F. Y. Bois, A. Gelman, J. Jiang, D. R. Maszle, L. Zeise, and G. Alexeef. Population toxicokinetics of tetrachloroethylene. OEHHA Technical Report, CAL/EPA (1995).Arch. Toxicol. (submitted)
Author information
Authors and Affiliations
Additional information
The opinions presented in this article are those of the authors and do not represent the views or policies of the Food and Drug Administration.
Rights and permissions
About this article
Cite this article
Ludden, T.M., Gillespie, W.R. & Bachman, W.J. Commentary on “physiologically based pharmacokinetic modeling as a tool for drug development”. Journal of Pharmacokinetics and Biopharmaceutics 23, 231–235 (1995). https://doi.org/10.1007/BF02354274
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02354274